These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33830701)

  • 61. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
    Hill JA; Ujjani CS; Greninger AL; Shadman M; Gopal AK
    Cancer Cell; 2021 Aug; 39(8):1037-1038. PubMed ID: 34242571
    [No Abstract]   [Full Text] [Related]  

  • 62. Double standards redux.
    Macklin R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908355
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vaccination in the context of the COVID-19 pandemic.
    Díaz-Badillo Á; Garibay-Nieto GN; Navas-Figueroa AL; Perales-Torres AL; Morales-Gómez MC; López-Alvarenga JC
    Cir Cir; 2021; 89(6):836-843. PubMed ID: 34851594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spotlight on Vaccines: Pandemic May Open Gateway to Improve Vaccination Rates in Texas.
    Price S
    Tex Med; 2021 Mar; 117(3):20-25. PubMed ID: 34855954
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Development and outlook on human challenge trial of vaccine].
    Han BF; Huang NH; Chen LY; Zhao TS; Liu HY; Zhang SH; Wang Y; Zheng H; Liu B; Wang C; Liu YQ; Lu QB; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1371-1375. PubMed ID: 34814556
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel strategies to support global promotion of COVID-19 vaccination.
    Wood S; Pate MA; Schulman K
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34649869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines?
    Lee H; Punt JA; Patel J; Stojanovic MP; Duszynski B; McCormick ZL;
    Pain Med; 2021 Jun; 22(6):1441-1464. PubMed ID: 33839780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated.
    Sprengholz P; Eitze S; Korn L; Siegers R; Betsch C
    Eur J Intern Med; 2021 May; 87():106-108. PubMed ID: 33810941
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines.
    Palomares F; Paris JL; Labella M; Doña I; Mayorga C; Torres MJ
    Allergy; 2022 Dec; 77(12):3527-3537. PubMed ID: 35912413
    [TBL] [Abstract][Full Text] [Related]  

  • 70. COVID-19 vaccines: What dermatologists should know?
    Ayatollahi A; Hosseini H; Firooz R; Firooz A
    Dermatol Ther; 2021 Sep; 34(5):e15056. PubMed ID: 34232548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines.
    Greenhawt M; Shaker M; Golden DBK
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3321-3322. PubMed ID: 34393075
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
    Mayo S; Monfort S
    J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
    [No Abstract]   [Full Text] [Related]  

  • 73. COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1943-1944. PubMed ID: 34128563
    [No Abstract]   [Full Text] [Related]  

  • 74. Commentary: Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations.
    Teo J
    Front Public Health; 2021; 9():723583. PubMed ID: 34395375
    [No Abstract]   [Full Text] [Related]  

  • 75. COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group.
    Kim MA; Lee YW; Kim SR; Kim JH; Min TK; Park HS; Shin M; Ye YM; Lee S; Lee J; Choi JH; Jang GC; Chang YS
    Allergy Asthma Immunol Res; 2021 Jul; 13(4):526-544. PubMed ID: 34212542
    [TBL] [Abstract][Full Text] [Related]  

  • 76. What does 95% COVID-19 vaccine efficacy really mean?
    Olliaro P
    Lancet Infect Dis; 2021 Jun; 21(6):769. PubMed ID: 33609458
    [No Abstract]   [Full Text] [Related]  

  • 77. Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective.
    Phillips EJ
    JAMA Netw Open; 2021 Aug; 4(8):e2122326. PubMed ID: 34463751
    [No Abstract]   [Full Text] [Related]  

  • 78. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    Skowronski DM; De Serres G
    N Engl J Med; 2021 Apr; 384(16):1576-1577. PubMed ID: 33596348
    [No Abstract]   [Full Text] [Related]  

  • 79. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

  • 80. Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines.
    Lee J; Woodruff MC; Kim EH; Nam JH
    Exp Mol Med; 2023 Jul; 55(7):1305-1313. PubMed ID: 37430088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.